Jan-Malte Sinning

Showing 1-19 of 19 articles

Interventions for valvular disease

Myocardial fibrosis in patients undergoing transcatheter aortic valve replacement: impact on left ventricular reverse remodeling and long-term outcome

Sugiura A, Weber M, von Depka A, Tabata N, Shamekhi J, Al-Kassou B, Nickenig G, Werner N, Sinning J-M, Sedaghat A

September 17, 2019 | 10.4244/EIJ-D-19-00641

Interventions for valvular disease

Combination of high-sensitivity C-reactive protein with logistic EuroSCORE improves risk stratification in patients undergoing TAVI

Stundl A, Busse L, Leimkühler P, Weber M, Zur B, Mellert F, Grube E, Nickenig G, Werner N, Sinning J-M

August 24, 2018 | 10.4244/EIJ-D-18-00059

Interventions for valvular disease

In vitro hydrodynamic and acute clinical performance of a novel self-expanding transcatheter heart valve in various surgical bioprostheses

Sedaghat A, Sinning J-M, Werner N, Nickenig G, Conradi L, Toggweiler S, Schäfer U

April 20, 2018 | 10.4244/EIJ-D-17-00844

Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis

Spaziano M, Mylotte D, Theriault-Lauzier P, De Backer O, Søndergaard L, Bosmans J, Debry N, Modine T, Barbanti M, Tamburino C, Sinning J-M, Grube E, Nickenig G, Mellert F, Bleiziffer S, Lange R, de Varennes B, Lachapelle K, Martucci G, Piazza N

November 20, 2017 | 10.4244/EIJ-D-16-00303

Interventions for valvular disease

Two sides to every story: the trade-off between paravalvular leakage and the occurrence of conduction disturbances in transcatheter heart valves

Sinning J-M, Grube E

September 20, 2017 | 10.4244/EIJV13I7A113

Interventions for valvular disease

The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation

Sinning J-M, Hammerstingl C, Schueler R, Neugebauer A, Keul S, Ghanem A, Mellert F, Schiller W, Müller C, Vasa-Nicotera M, Zur B, Welz A, Grube E, Nickenig G, Werner N

April 20, 2016 | 10.4244/EIJY15M02_02

Interventions for valvular disease

New expandable mitral annuloplasty ring facilitates transcatheter mitral valve implantation: proof of concept

Duerr G, Sinning J-M, Mellert F

April 8, 2016 | 10.4244/EIJV11I14A318

Interventions for valvular disease

Balloon post-dilation and valve-in-valve implantation for the reduction of paravalvular leakage with use of the self-expanding CoreValve prosthesis

Stundl A, Rademacher M-C, Descoups C, Weber M, Sedaghat A, Grube M, Hammerstingl C, Mellert F, Vasa-Nicotera M, Welz A, Grube E, Werner N, Nickenig G, Sinning J-M

February 19, 2016 | 10.4244/EIJY15M11_04

Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis

Sedaghat A, von Dobbeler C, Sontag B, Sinning J-M, Fimmers R, Mellert F, Schiller W, Welz A, Grube E, Nickenig G, Hauptmann K-E, Werner N

October 20, 2015 | 10.4244/EIJY15M01_10

Doppler-based renal resistance index for the detection of acute kidney injury and the non-invasive evaluation of paravalvular aortic regurgitation after transcatheter aortic valve implantation

Sinning J-M, Adenauer V, Scheer A, Cachiguango S, Ghanem A, Hammerstingl C, Sedaghat A, Müller C, Vasa-Nicotera M, Grube E, Nickenig G, Werner N

March 20, 2014 | 10.4244/EIJV9I11A221

Decrease of pulmonary hypertension impacts on prognosis after transcatheter aortic valve replacement

Sinning J-M, Hammerstingl C, Chin D, Ghanem A, Schueler R, Sedaghat A, Bence J, Spyt T, Werner N, Kovac J, Grube E, Nickenig G, Vasa-Nicotera M

January 20, 2014 | 10.4244/EIJV9I9A177

Transcatheter valve implantation improves central sleep apnoea in severe aortic stenosis

Linhart M, Pabst S, Fistera R, Ghanem A, Sinning J-M, Hammerstingl C, Kozhuppakalam F, Grube E, Werner N, Nickenig G, Skowasch D

December 27, 2013 | 10.4244/EIJV9I8A155

Challenges in transcatheter valve treatment: aortic regurgitation after transcatheter aortic valve implantation

Sinning J-M, Werner N, Nickenig G, Grube E

September 15, 2013 | 10.4244/EIJV9SSA14

Medtronic CoreValve Evolut R with EnVeo R

Sinning J-M, Werner N, Nickenig G, Grube E

September 15, 2013 | 10.4244/EIJV9SSA18

Prognostic value of cerebral injury following transfemoral aortic valve implantation

Ghanem A, Müller A, Sinning J-M, Kocurek J, Becker B, Vogel M, Vasa-Nicotera M, Hammerstingl C, Schwab J, Nähle C, Thomas D, Wagner M, Grube E, Werner N, Nickenig G

March 22, 2013 | 10.4244/EIJV8I11A198

Medtronic CoreValve Evolut valve

Sinning J-M, Werner N, Nickenig G, Grube E

September 30, 2012 | 10.4244/EIJV8SQA17

Transcatheter aortic valve implantation and closure of the left atrial appendage under cerebral protection

Sinning J-M, Hammerstingl C, Vasa-Nicotera M, Grube E, Werner N, Nickenig G, Ghanem A

September 28, 2012 | 10.4244/EIJV8I5A98

First-in-man use of a novel embolic protection device for patients undergoing transcatheter aortic valve implantation

Naber C, Ghanem A, Abizaid A, Wolf A, Sinning J-M, Werner N, Nickenig G, Schmitz T, Grube E

May 15, 2012 | 10.4244/EIJV8I1A8

Huge saphenous vein graft aneurysm after coronary artery bypass grafting

Sinning J-M, Lasek G, Nickenig G, Werner N

February 21, 2011

Latest news

New issue

TAVR in sarcopaenia; CCTA or TEE in LAAC; Iintravascular lithotripsy, read the new issue

(CT scans of a sarcopaenic patient)

October 18, 2019

Free access

Medical device regulation in Europe – what is changing and how can I become more involved?

October 18, 2019

Free Access

New this week: Hydrodynamic function with the ALLEGRA heart valve

October 15, 2019

Free access

Guidelines, consensus & position papers

April 9, 2019

Editorial

When is it best to stop aspirin and who could ultimately benefit?

Aspirin-free antiplatelet regimens after PCI

October 9, 2019

Free Access

Last week's JAA's: 3D printing in TAVI, QFR SYNTAX score and non-obstructive disease

October 8, 2019

Free access

The EuroIntervention health check 2019

October 4, 2019

Jan-Malte Sinning

Latest news

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke